medigraphic.com
ISSN 1527-3172 (Electronic)

2017, Number 4

<< Back Next >>

MEDICC Review 2017; 19 (4)

Human evolutionary carcinogenesis and effects of demographic and epidemiologic transitions in low- and middle-income countries

Pérez-Cala AE, Benítez-Sánchez E

Language: English
References: 52
Page: 35-42
PDF size: 118.92 Kb.


ABSTRACT

INTRODUCTION In many countries cancer is or threatens to become the leading cause of death, although incidence and mortality rates differ between high-income and low- and middle-income countries. Developments in evolutionary biology have revealed that carcinogenesis is even more complex than previously thought. Several theories attempt to integrate the various existing points of view about what is known to date.
OBJECTIVES Analyze and explain the main current theories of carcinogenesis and explore their possible application to understanding the demographic and epidemiologic transitions’ effects on cancer population dynamics in low- and middle-income countries.
EVIDENCE ACQUISITION A systematic literature review was carried out in MEDLINE (via PubMed), SCOPUS (via ScienceDirect) and SciELO. Consistency and quality of evidence in articles reviewed were taken into account; we excluded studies with consistency levels of IV and V, and those with limited or insufficient quality of evidence.
DEVELOPMENT Human evolution has led to a type of life history characterized by numerous tradeoffs with oncogenic implications. Cultural coevolution and socioeconomic development have affected cancer population dynamics. Several theories explain carcinogenesis from an ecological and evolutionary perspective, among them somatic mutation, adaptive oncogenesis, life history theories, and the Noble and Hochberg model. The human environmental effect on cancer risk is manifested in the influence of demographic and epidemiologic transitions in low- and middle-income countries, where cancer represents a high disease burden due to the effects of recently introduced environmental factors in native environments, accentuation of adaptive decoupling, and diversification of genetic polymorphisms for cancer susceptibility.
CONCLUSIONS The Noble and Hochberg model best explains the population dynamics of cancer in low- and middle-income countries, especially regarding the effects of recently introduced environmental factors on native environments, adaptive decoupling and genetic diversity (manifest in differences in clinical and biological tumor expression by level of economic development), in response to demographic and epidemiologic transitions.


REFERENCES

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359–86.

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 Mar–Apr;61(2):69–90.

  3. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2016. Havana: Ministry of Public Health (CU); 2017. 206 p. Spanish.

  4. Domínguez E, Santana F, Seuc AH, Galán Y. Años de vida ajustados por discapacidad por cáncer de mama y del sistema reproductor en mujeres cubanas en edad fértil. MEDICC Rev [Internet]. 2014 Jul–Oct [cited 2016 Oct 23];16(3–4). Available from: http://www.medicc.org/mediccreview/index .php?issue=36&id=480&a=va. Spanish.

  5. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends—An Update. Cancer Epidemiol Biomarkers Prev [Internet]. 2016 Jan [cited 2017 Feb 5];25(1):16–27. Available from: http://cebp .aacrjournals.org/cgi/pmidlookup?view=long&pm id=26667886

  6. Siegel R, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

  7. Jemal A, Bray F, Forman D, O’Brian M, Ferlay J, Center M, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012 Sep 15;118(18):4372–84.

  8. Curado MP, de Souza DL. A global perspective on cancer burden in Latin America and the Caribbean. Ann Glob Health. 2014 Sep–Oct;80(5):370–7.

  9. Sierra MS, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiol. 2016 Sep;44 Suppl 1:S23–S42.

  10. Bray F, Piñeros M. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Pública Méx. 2016 Apr;58(2):104–17.

  11. McCormack VA, Boffeta P. Today’s lifestyles, tomorrow’s cancers. Trends in lifestyles risk factors for cancer in low and middle-income countries. Ann Oncol. 2011 Nov;22(11):2349–57.

  12. Thomas F, Fisher D, Fort P, Marie JP, Daoust S, Roche B, et al. Applying ecological and evolutionary theory to cancer: a long and winding road. Evol Appl. 2013 Jan;6(1):1–10.

  13. Higgings JPT, Altman DG, Sterne AC. Assessing risk of bias in included studies. In: Higgings JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) [Internet]. London: Cochrane.org; 2011 Mar [cited 2016 Oct 30]. Available from: http://handbook-5-1 .cochrane.org/

  14. Tomassetti C, Vogelstein B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015 Jan 2;347(6217):78–81.

  15. Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 2017 Mar;355:1330–4.

  16. Wu S, Powers S, Zhu W, Hannun YA. Substantial contribution of extrinsic risk factors to cancer development. Nature. 2016 Jan 7;529(7584):43–7.

  17. Weinberg CR, Zaykin D. Is bad luck the main cause of cancer? J Natl Cancer Inst. 2015 May 8;107(7): pii: djv125. DOI: 10.1093/jnci/djv125.

  18. Potter JD, Prentice RL. Cancer risk: tumor excluded. Science. 2015 Feb 13;347(6223):727.

  19. Gotay C, Dummer T, Spinelli J. Cancer risk: prevention is crucial. Science. 2015 Feb 13;347(6223):728.

  20. Fox EJ, Salk JJ, Loeb LA. Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer. Genome Med. 2016 Mar 17;8(1):30.

  21. Sornette D, Favre M. Debunking mathematically the logical fallacy that cancer risk is just “bad luck”. EPJ Nonlinear Biomed Physics. 2015 Dec 1;3–10.

  22. Albini A, Cavuto S, Apolone G, Noonan DM. Strategies to Prevent “Bad Luck” in Cancer. JNCI J Natl Cancer Inst [Internet]. 2015 Aug 4 [cited 2016 Nov 5];107(10). Available from: https://www.ncbi.nlm .nih.gov/pmc/articles/pmid/26242894/

  23. Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954 Mar;8(1):1–22.

  24. Hao D, Wang L, Di LJ. Distinct mutation accumulation rates among tissues determine the variation in cancer risk. Sci Rep. 2016 Jan 20;6:19458.

  25. Martincorena I, Campbell PJ. Somatic mutation in cancer and normal cells. Science. 2015 Sep 25;349(6255):1483–9.

  26. Petkova R, Chakarov S. The fi nal checkpoint. Cancer as an adaptive evolutionary mechanism. J Biotech Biotechnol Equip. 2016 Feb 24;30(3):434–42.

  27. DeGregori J. Challenging the axiom: Does the occurrence of oncogenic mutations truly limit cancer development with age. Oncogene. 2013 Apr 11;32(15):1869–75.

  28. Rozhok AI, DeGregori J. The evolution of lifespan and age-dependent cancer risk. Trends Cancer [Internet]. 2016 Oct [cited 2017 Apr 12];2(10):552–60. Available from: http://www.ucdenver.edu/academics/ colleges/medicalschool/departments/biochemistry/ Research/researchlabs/DeGregoriLab/Documents/ Rozhok_DeGregori_TrendsCancer.pdf

  29. Gatenby RA, Brown J. Mutations, evolution and the central role of a self-defi ned fi tness function in the initiation and progression of cancer. Biochim Biophys Acta. 2017 Apr;1867(2):162–6.

  30. Rozhok A, DeGregori J. Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations. Proc Natl Acad Sci USA. 2015 Jul 21;112(29):8914–21.

  31. Peto R, Roe FJ, Lee PN, Levy L, Clack J. Cancer and ageing in mice and men. Br J Cancer. 1975 Oct;32(4):411–26.

  32. Kokko H, Hochberg ME. Towards cancer-aware life-history modelling. Philos Trans R Soc Lond B Biol Sci [Internet]. 2015 Jul 19 [cited 2016 Nov 23];370: pii: 20140234. Available from: http:// dx.doi.org/10.1098/rstb.2014.0234

  33. Aktipis CA, Boddy AM, Jansen G, Hibner U, Hochberg ME, Maley CC, et al. Cancer across the tree of life: cooperation and cheating in multicellularity. Philos Trans R Soc Lond B Biol Sci [Internet]. 2015 Apr 30 [cited 2016 Nov 10];370(1673). pii: 20140219. Available from: http://dx.doi .org/10.1098/rstb.2014.0219

  34. Boddy AM, Kokko H, Breden F, Wilkinson GS, Aktipis CA. Cancer susceptibility and reproductive trade-offs: a model of the evolution of cancer defences. Philos Trans R Soc Lond B Biol Sci [Internet]. 2015 Jun 8 [cited 2016 Nov 23];370. pii: 20140220. Available from: http://dx.doi .org/10.1098/rstb.2014.0220

  35. Brown JS, Aktipis CA. Inclusive fi tness effects can select for cancer suppression into old age. Phil Trans R Soc B [Internet]. 2015 [cited 2016 Nov 25];370:20150160. Available from: http://dx.doi .org/10.1098/rstb.2015.0160

  36. Brown JS, Cunningham JJ, Gatenby RA. The multiple facets of Peto’s paradox: a life-history model for the evolution of cancer suppression. Phil Trans R Soc B [Internet]. 2015 [cited 2016 Nov 25];370:20140221. Available from: http://dx.doi .org/10.1098/rstb.2014.0221

  37. Aktipis CA, Boddy AM, Gatenby RA, Brown JS, Maley CC. Life history trade-offs in cancer evolution. Nat Rev Cancer [Internet]. 2013 Dec [cited 2016 Dec 4];13(12):883–92. Available from: http:// dx.doi.org/10.1038/nrc3606

  38. Hochberg ME, Noble RJ. A framework for how environment contributes to cancer risk. Ecol Lett. 2017 Feb;20(2):117–34.

  39. Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015 Aug;5(8):806–20.

  40. Brinton LA, Figueroa JD, Awuah B, Yarney J, Wiafe S, Wood S, et al. Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat. 2014 Apr;144(3):467–78.

  41. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368(8):728–36.

  42. Riosmena F, Wong R, Palloni A. Migration selection, protection, and acculturation in health: a binational perspective on older adults. Demography. 2013 Jun; 50(3):1039–64.

  43. Chena R, Rena S, Yiub MK, Faic NC, Cheng WS; Chinese Prostate Cancer Consortium, et al. Prostate cancer in Asia: A collaborative report. Asia J Urol. 2014 Oct;1(1):15–29.

  44. Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in Asia-Pacifi c region. Cancer Biol Med. 2014 Jun;11(2):101–15.

  45. Jedy-Agba E, McCormack V, Adebamowo C, dos-Santos-Silva I. Stage at diagnosis of breast cancer in sub-saharian Africa: a systematic review and meta-analysis. Lancet Glob Health. 2016 Dec;4(12):e926–e35.

  46. Falandry C, Bonnefoy M, Freyes G, Gilson E. Biology of cancer and aging: A complex association with cellular senescence. J Clin Oncol. 2014 Aug 20;32(24):2604–10.

  47. Amadou A, Torres-Mejía G, Hainaut P, Romieu I. Breast cancer in Latin America: global burden, patterns, and risk factors. Salud Pública Méx. 2014 Sep–Oct;56(5):547–54.

  48. Villarreal-Garza C, Águila C, Magallanes-Hoyos MC, Mohar A, Bargalló E, Meneses A, et al. Breast cancer in young women in Latin America: an unmet, growing burden. Oncologist. 2013;18 Suppl:26–34.

  49. Ferlay J, Forman D, Mathers CD, Bray F. Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet. 2012;379:1390–1.

  50. Franco-Marina F, López-Carrillo L, Keating NL, Arreola-Ornelas H, Marie Knaul F. Breast cancer age at diagnosis patterns in four Latin American Populations: A comparison with North American countries. Cancer Epidemiol. 2015 Dec;39(6):831–7. Epub 2015 Oct

  51. Rocha-Brischiliari SC, Oliveira RR, Andrade L, Brischiliari A, Gravena AA, Carvalho MD, et al. The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil. PLoS One. 2017 Jan 3;12(1):e0168950.

  52. Cavalli F. Cáncer. El gran desafío [Internet]. Habana: Editorial Ciencias Médicas; 2012 [cited 2016 Dec 5]. Available from: http://www.bvs.sld. cu/libros/cancer_gran_desafio/indice_p.htm. Spanish.




2020     |     www.medigraphic.com